Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-11-06
|
5-day change | 1st Jan Change | ||
| 42.12 CNY | -0.85% |
|
+4.52% | -7.67% |
| Market Cap | 27.47B 4.11B 3.69B 3.37B 3.08B 5.8B 387B 5.98B 40.64B 16.21B 206B 15.44B 15.11B 651B | P/E 2026 * |
31.4x | P/E 2027 * | 27.4x |
|---|---|---|---|---|---|
| Enterprise Value | 27.47B 4.11B 3.69B 3.37B 3.08B 5.8B 387B 5.98B 40.64B 16.21B 206B 15.44B 15.11B 651B | EV / Sales 2026 * |
5.57x | EV / Sales 2027 * | 5.13x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.85% | ||
| 1 week | +4.52% | ||
| Current month | +4.52% | ||
| 1 month | +19.25% | ||
| 3 months | +13.29% | ||
| 6 months | +0.21% | ||
| Current year | -7.67% |
| 1 week | 41.03 |  | 43.42 |
| 1 month | 35.53 | | 43.42 |
| Current year | 33.83 | | 48.2 |
| 1 year | 33.83 | | 50.95 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Chen
CEO | Chief Executive Officer | 56 | 2026-09-03 |
Jian Ma
DFI | Director of Finance/CFO | 42 | - |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Zhou
BRD | Director/Board Member | 56 | 2019-05-14 |
Jian Hua Xing
BRD | Director/Board Member | 55 | 2021-12-09 |
Lei Wang
BRD | Director/Board Member | 55 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.85% | +4.52% | -14.22% | +38.64% | 4.11B | |
| -0.79% | -4.48% | +46.48% | +125.69% | 1,206B | |
| +1.43% | +1.11% | +48.05% | +83.05% | 665B | |
| +1.07% | -1.21% | +32.92% | +104.92% | 515B | |
| -0.36% | -3.25% | +45.42% | +65.10% | 381B | |
| -0.14% | -1.87% | +70.06% | +41.09% | 362B | |
| -0.78% | -0.52% | +30.47% | +58.09% | 307B | |
| -0.80% | -0.21% | +7.98% | +36.17% | 289B | |
| +0.03% | -1.20% | +43.79% | +69.83% | 249B | |
| -0.41% | -2.22% | +40.43% | +107.03% | 207B | |
| Average | -0.16% | -1.48% | +35.14% | +72.96% | 418.39B | |
| Weighted average by Cap. | -0.05% | -1.96% | +42.65% | +88.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 738M 662M 605M 552M 1.04B 69.41B 1.07B 7.3B 2.91B 37.03B 2.77B 2.71B 117B | 5.35B 801M 719M 657M 600M 1.13B 75.32B 1.17B 7.92B 3.16B 40.19B 3.01B 2.94B 127B |
| Net income | 1.04B 155M 139M 127M 116M 219M 14.58B 226M 1.53B 611M 7.78B 582M 570M 24.56B | 1.18B 177M 159M 145M 133M 250M 16.67B 258M 1.75B 698M 8.89B 665M 651M 28.07B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | CN¥42.12 | -0.85% | 3,382,210 |
| 26-11-05 | CN¥42.48 | -0.07% | 4,622,300 |
| 26-11-04 | CN¥42.51 | -0.93% | 5,677,106 |
| 26-11-03 | CN¥42.91 | +0.87% | 5,728,373 |
| 26-11-02 | CN¥42.54 | +5.56% | 9,699,456 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
42.12
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
